ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ — ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing…